Boston Scientific (MEX:BSX) Moat Score: 7/10 (As of Jul. 05, 2026)


MEX:BSX Boston Scientific Corp MEX:BSX
85 GF Score
Price MXN784.12
GF Value MXN1,834.19
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Moat Score?

Boston Scientific MEX:BSX 85 Moat Score is 7 as of Jul. 05, 2026. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,834.19 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 845 Medical Devices & Instruments companies, Boston Scientific ranks better than 98.93% on this metric.

Boston Scientific has the Moat Score of 7, which implies that the company might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Boston Scientific has Wide Moat: BSX has a strong position in medical devices with valuable patents, significant R&D capabilities, and regulatory barriers. Its brand strength and customer loyalty contribute to a durable competitive advantage.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Boston Scientific might have Wide Moat - Entry-level wide moat, clearly possessing durable advantages.

Boston Scientific  (MEX:BSX) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Boston Scientific Moat Score Related Terms

MEX:BSX vs EW, GEHC, MDT: Moat Score Comparison

For the Medical Devices subindustry, Boston Scientific's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boston Scientific Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Moat Score distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Moat Score falls into.


MEX:BSX
85GF Score
Boston Scientific Corp MEX:BSX
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 7 mean?
Boston Scientific (MEX:BSX) has a Moat Score of 7 as of Jul. 05, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Boston Scientific ranks #9 out of 845 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Boston Scientific's Moat Score too high?
Boston Scientific's current Moat Score is 7. Based on the distribution chart, Boston Scientific ranks #9 out of 845 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Moat Score compare to EW and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Boston Scientific ranks #9 out of 845 companies for Moat Score. This places Boston Scientific in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Boston Scientific's current Moat Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,834.19, compared to a current price of MXN784.12 — trading 57.2% below its estimated fair value. The current Moat Score is 7. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Moat Score is 7 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN784.12 is trading 57.2% below its estimated GF Value™ of MXN1,834.19. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Moat Score: 7
  • GF Value™: MXN1,834.19 vs. price of MXN784.12 (57.2% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score

Get the complete analysis for MEX:BSX

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN784.12
Price
MXN1,834.19
GF Value